Researchers Identify Test-Negative Design As “Least Biased And Most Efficient” To Measure COVID-19 Vaccine Effectiveness In Patients With CKD

Healio (3/27, Keenan) reports, “Researchers identified a test-negative design as the ‘least biased and most efficient’ to measure COVID-19 vaccine effectiveness in patients with chronic kidney disease” (CKD), according to findings published online ahead o...